Functionalized nanoparticles crossing the brain–blood barrier to target glioma cells

Glioma is the most common tumor of the central nervous system (CNS), with a 5-year survival rate of <35%. Drug therapy, such as chemotherapeutic and immunotherapeutic agents, remains one of the main treatment modalities for glioma, including temozolomide, doxorubicin, bortezomib, cabazitaxel, dih...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yongyan, Qian, Yufeng, Peng, Wei, Qi, Xuchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Biochemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327649/
https://www.ncbi.nlm.nih.gov/pubmed/37426416
http://dx.doi.org/10.7717/peerj.15571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327649/
https://www.ncbi.nlm.nih.gov/pubmed/37426416
http://dx.doi.org/10.7717/peerj.15571

Ejemplares similares